Regarding autophagy induction for breast cancer therapy, a promising approach is to target the formation of Bcl-2/Bcl-XL-Beclin1 complexes by using selective Bcl-2 inhibitors [194] (Figure 4). Here, BCL2 is linked to breast carcinoma.